These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8463439)

  • 1. Clinical use of androgenic steroids at a major medical center: who prescribes androgens and how well do they do it?
    Cavanah SF; Jacobson JM; McIntyre T
    J Clin Pharmacol; 1993 Mar; 33(3):253-8. PubMed ID: 8463439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action mechanism of synthetic androgens].
    Matsumoto K; Namiki M
    Nihon Rinsho; 1994 Mar; 52(3):600-5. PubMed ID: 8164356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
    Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
    Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based patterns of prescription androgen use, 1976-2008.
    Hall SA; Ranganathan G; Tinsley LJ; Lund JL; Kupelian V; Wittert GA; Kantoff PW; Morales A; Araujo AB
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):498-506. PubMed ID: 24510484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.
    Zhou CK; Advani S; Chaloux M; Gibson JT; Yu M; Bradley M; Hoover RN; Cook MB
    J Urol; 2020 Jun; 203(6):1184-1190. PubMed ID: 31928462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapy for Male Hypogonadism.
    Carrasquillo R; Chu K; Ramasamy R
    Curr Urol Rep; 2018 Jun; 19(8):63. PubMed ID: 29886559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.
    Morales A; Johnston B; Heaton JP; Lundie M
    J Urol; 1997 Mar; 157(3):849-54. PubMed ID: 9072584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.
    Jasuja GK; Bhasin S; Reisman JI; Hanlon JT; Miller DR; Morreale AP; Pogach LM; Cunningham FE; Park A; Berlowitz DR; Rose AJ
    J Gen Intern Med; 2017 Mar; 32(3):304-311. PubMed ID: 27995426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapy of male hypogonadism.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deficiency in the etiology and treatment of erectile dysfunction.
    Gore JL; Swerdloff RS; Rajfer J
    Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction.
    Bunch TJ; Abraham D; Wang S; Meikle AW
    Aging Male; 2002 Mar; 5(1):38-46. PubMed ID: 12040974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
    Morgentaler A; Dobs AS; Kaufman JM; Miner MM; Shabsigh R; Swerdloff RS; Wang C
    J Urol; 2008 Dec; 180(6):2307-13. PubMed ID: 18930255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marketing and Testosterone Treatment in the USA: A Systematic Review.
    Bandari J; Ayyash OM; Emery SL; Wessel CB; Davies BJ
    Eur Urol Focus; 2017 Oct; 3(4-5):395-402. PubMed ID: 29174614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various modes of androgen substitution therapy on erythropoiesis.
    Jockenhövel F; Vogel E; Reinhardt W; Reinwein D
    Eur J Med Res; 1997 Jul; 2(7):293-8. PubMed ID: 9233903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A UK epidemic of testosterone prescribing, 2001-2010.
    Gan EH; Pattman S; H S Pearce S; Quinton R
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):564-70. PubMed ID: 23480258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
    Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
    J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular morphology in hypogonadotropic hypogonadism after the abuse of anabolic steroids.
    Alibegović A
    Forensic Sci Med Pathol; 2018 Dec; 14(4):564-567. PubMed ID: 30175397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone and depression in aging men.
    Seidman SN; Walsh BT
    Am J Geriatr Psychiatry; 1999; 7(1):18-33. PubMed ID: 9919317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.